#AccessToHealthCare WIG Webinar: Biomarker Testing and Personalized Healthcare: Opportunities to Address Disparities and Improve Outcomes in Cancer Care

Biomarker testing is increasingly important in cancer care, allowing providers to determine which targeted therapies will work for which patients. Learn how biomarker testing and targeted therapies impact patients and about policy opportunities to reduce disparities and improve patient access to the personalized treatments. 

• Washington SB 5822: Concerning Insurance Converage for Biomarker Testing
• Washington HB 1689: Exempting Biomarker Testing from Prior Authorization for Patients with Late Stage Cancer
• Illinois HB 1779: Ins - Biomarker Testing
• Fight Cancers
• Health Equity in Biomarker Testing and Targeted Therapy
• Biomarker Testing: Advancing Precision Medicine in Cancer Care
• Biomarkers and Advancements in Cancer Care
• Illinois Biomarker Testing video
• NCSL Biomarker Testing information (scroll down to biomarker & precision medicine tab)
• NCSL - New Era of Cancer Treatment and Diagnosis 
• ACS-CAN Health Equity in Biomarker Testing and Targeted Therapy
• ACS-CAN Improving Access to Biomarker Testing 
• Advancing Health Equity, Addressing Cancer Disparities
• Biomarker Testing
• Cancer Disparities
• Cancer in the 21st Century
• Common Cancer Testing Terminology
• Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States
• Know Your Biomarker
• No One Missed
• OAS Episode 138 Transcription
• Precision Medicine